Abstract: A system for micro-segmented networking is provided. A system controller is programmed to a) store a plurality of micro-segmented network accounts and a plurality of subscriber accounts, b) receive a request from a user device to activate a first micro-segmented network associated with a first subscriber account, c) authenticate the first subscriber account based on the subscriber information, d) activate the first micro-segmented network, including a plurality of device slots for a plurality of devices, e) transmit, to the user device, first device slot authentication information for a first device slot of the plurality of device slots; f) receive, from a first device connecting to the wireless network, the first device slot authentication information; g) authenticate the first device slot authentication information; and h) in response to authenticating the first device slot authentication information, connect the first device to the first micro-segmented network.

Abstract: This disclosure relates to a composition, a system and a method of reducing and preventing the growth of microbes, or for killing microbes. More particularly, the disclosure relates to a composition, a system and a method of reducing and preventing growth of microbes, or for killing microbes, e.g., in food and medical equipment containers, using polymers entrained with antimicrobial agents.

Abstract: An example method performed by a processing system includes receiving a request from a first user to render an extended reality environment, wherein the request includes a definition of a first policy that governs user behavior within the extended reality environment, rendering the extended reality environment by presenting content contributed by at least one user in the extended reality environment, monitoring the extended reality environment to ensure that the rendering results in a compliance of the extended reality environment with the first policy, detecting that a portion of the content contributed by at least one other user of the extended reality environment results in the extended reality environment failing to comply with the first policy, and modifying a presentation of the portion of content in the extended reality environment in response to the detecting, wherein the modifying results in the compliance of the extended reality environment with the first policy.

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R6, X1, and X2 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: Client-based search query autocomplete is disclosed. A search engine server system sends a search web page of a search engine to a content distribution network (CDN) server system for delivery to a client computing device. The search web page includes a query dialog box and an autocomplete service that is configured to present search query suggestions on a display device. The search engine server system receives, from the CDN server system, a search query list request for a predetermined list of search query suggestions, the search query list request originating from the autocomplete service of the search web page executing on the client computing device. The search engine server system sends the predetermined list of search query suggestions to the CDN server system for delivery to the client computing device.

Abstract: The present invention provides for compounds of formula (I) wherein R1, Y, X1, X2, R2, R3, R4, R5, R6, and m have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: Client-based search query autocomplete is disclosed. A search engine server system sends a search web page of a search engine to a content distribution network (CDN) server system for delivery to a client computing device. The search web page includes a query dialog box and an autocomplete service that is configured to present search query suggestions on a display device. The search engine server system receives, from the CDN server system, a search query list request for a predetermined list of search query suggestions, the search query list request originating from the autocomplete service of the search web page executing on the client computing device. The search engine server system sends the predetermined list of search query suggestions to the CDN server system for delivery to the client computing device.

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R6, X1, and X2 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: A gutter hanger includes a main body; a rear clip at a first end of the main body; a front hook at a second end of the body; at least one guide tab extending from the main body, the at least one guide tab sized and positioned to align a drive tool relative to the main body.

Abstract: The present invention provides for compounds of formula (I) wherein R1, Y, X1, X2, R2, R3, R4, R5, R6, and m have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R6, Y1, Y2, Y3, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).

Abstract: The present invention provides for compounds of formula (I) wherein R1, Y, L1, G1, X1, X2, L2, R2, R3, and R4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R6, Y1, Y2, Y3, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R6, X1, and X2 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R6, X1, and X2 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: The present disclosure relates to enzyme formulations and methods of using the enzyme formulations to reduce the viscosity of fluids used in hydrocarbon recovery. Some embodiments provide particles for well treatment, where the particles comprise an acidifier carrier and an enzyme co-encapsulated within a shell. The particles can, for example, allow a delayed or controlled release of the enzyme in a high temperature, high pressure environment.

Abstract: Provided are compounds of formula (I), wherein R1, Y, X1, X2, R2, R3, R4, R5, R6 and m have any of the values defined in the specification and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R6, Y1, Y2, Y3, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).

Abstract: Provided herein are compounds of formula (I) wherein R1, Y, L1, G1, X1, X2, L2, R2, R3, and R4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, which are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R6, X1, and X2 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).